In a patient with Addison's disease presenting with generalized paresthesias and muscle cramps, what evaluation and management steps are recommended?

Paresthesias and Muscle Cramps in Addison's Disease

Immediate Evaluation Priority

Check serum electrolytes immediately—specifically sodium, potassium, and calcium—because paresthesias and muscle cramps in a patient with Addison's disease most commonly indicate electrolyte disturbances from inadequate mineralocorticoid replacement or glucocorticoid under-replacement. 1, 2

Diagnostic Approach

Key Laboratory Tests

• Hyponatremia is the most common electrolyte abnormality in Addison's disease and can cause generalized weakness, muscle cramps, and neurological symptoms. 1, 3
• Hyperkalemia frequently accompanies hyponatremia in primary adrenal insufficiency due to aldosterone deficiency. 1, 3
• Hypocalcemia should be excluded, as it can present with paresthesias, muscle cramps, and tetany—symptoms that may be mistakenly attributed to Addison's disease alone. 4
• Measure plasma renin activity to assess adequacy of mineralocorticoid replacement; elevated renin suggests under-replacement with fludrocortisone. 2

Clinical Assessment

• Evaluate for signs of glucocorticoid under-replacement: fatigue, nausea, poor appetite, weight loss, postural hypotension, and generalized weakness. 2
• Assess for mineralocorticoid under-replacement: salt craving, postural hypotension (sitting and standing blood pressure), and light-headedness. 2
• Inquire about recent illness, stress, or medication changes that may have increased cortisol requirements without appropriate dose adjustment. 1, 2

Management Strategy

Optimize Mineralocorticoid Replacement

• Adjust fludrocortisone dose (range 50–200 µg daily) based on clinical symptoms, blood pressure, and plasma renin activity; target plasma renin in the upper normal reference range. 2
• Ensure the patient is consuming adequate dietary sodium—sodium restriction must be avoided in Addison's disease. 2
• If the patient is taking prednisolone instead of hydrocortisone, a higher fludrocortisone dose is often required because prednisolone has limited mineralocorticoid activity. 2

Optimize Glucocorticoid Replacement

• Review the current hydrocortisone regimen (standard adult dosing is 15–25 mg daily in 2–3 divided doses, with the largest dose upon awakening). 2
• Increase hydrocortisone dose if there are signs of under-replacement or if the patient has been experiencing intercurrent illness or stress without appropriate dose adjustment. 1, 2
• Avoid long-acting synthetic glucocorticoids (prednisolone, dexamethasone) for routine replacement, as they are associated with greater adverse metabolic effects and reduced quality of life. 2

Address Hypocalcemia if Present

• If serum calcium is low, initiate calcium and vitamin D supplementation as appropriate. 4
• Hypocalcemia can coexist with Addison's disease, particularly in the context of autoimmune polyendocrine syndrome, and requires separate treatment. 4

Specific Pitfalls to Avoid

• Do not attribute all neuromuscular symptoms to Addison's disease alone—muscle spasm and paresthesias have been reported as presenting features of Addison's disease but may also indicate concurrent electrolyte disturbances (especially hypocalcemia) or other autoimmune conditions. 4, 5
• Do not prescribe diuretics (including thiazides or metolazone) to manage any comorbid condition, as they are absolutely contraindicated in Addison's disease and can precipitate adrenal crisis. 6
• Do not rely on a single morning cortisol or ACTH measurement to guide chronic glucocorticoid replacement; dose adjustments should be based on clinical response. 2
• Ensure the patient has been educated on stress-dosing protocols—infections and gastrointestinal illness are the most common triggers for adrenal crisis, and patients must understand when to double or triple their hydrocortisone dose and when to use intramuscular hydrocortisone. 2

Screening for Associated Autoimmune Conditions

• Screen for autoimmune thyroid disease, as it frequently coexists with primary adrenal insufficiency (autoimmune polyendocrine syndrome type 2). 2, 3
• Consider periodic screening for type 1 diabetes, celiac disease, vitiligo, and pernicious anemia based on clinical suspicion. 2, 3

Follow-Up and Monitoring

• Schedule endocrinology follow-up at least annually (or every 3–4 months for infants) to evaluate for signs of over- and under-replacement. 1, 2
• Reassess electrolytes, blood pressure, and clinical symptoms after any dose adjustment. 2
• Provide the patient with a steroid emergency card and a 100-mg hydrocortisone intramuscular kit for emergencies. 2